Indeed, there is increasing evidence that IL-17 and IL-22 may differentially play (dual) pathogenic and protective roles in inflammatory disease, depending on the particular disorder [102–104] with, for example, data from both animal models and human disease indicating that, in addition to its pathogenic role during the initiation phase of disease, IL-22 may play an inflammation-resolving role during established arthritis [105,106]. Here, IL22 is linked to Arthritis.